Bernadett Szabados

12PUBLICATIONS
77CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 07, 2026
Precision Immunotherapy: Revolutionizing Cancer Treatment With Targeted Innovations.

|Mar 20, 2026
CALYPSO: Final Results of Savolitinib and Durvalumab Combination in Metastatic Papillary Renal Cancer.

Francesca Jackson-Spence, James Larkin, Poulam Patel

|Mar 14, 2026
VEGF-TKI Outcomes in Metastatic Renal Cell Carcinoma According to Prior Immune Checkpoint Inhibitor or VEGF-TKI: A Scoping Review and Exploratory Analysis.

Elizabeth Nally, Agne Jovaisaite, Sara Coca Membribes

|Jan 30, 2026
Management of surgical menopause in female patients with bladder cancer undergoing radical cystectomy.

Elizabeth Day, Francesco Pio Bizzarri, Ciara Mackenzie

|Dec 03, 2025
Gemcitabine Intravesical System Plus Cetrelimab or Cetrelimab Alone as Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer: SunRISe-4 Primary Analysis and Biomarker Results.

Andrea Necchi, Félix Guerrero-Ramos, Paul L Crispen

|Nov 27, 2025
Towards biomarker-driven therapies for urothelial carcinoma.

Sara Coca Membribes, Bernadett Szabados, Thomas Powles

Pageof 2

Frequent Collaborators

4 joint publications

Thomas Powles

3 joint publications

Francesca Jackson-Spence

2 joint publications

Félix Guerrero-Ramos

2 joint publications

Andrea Necchi